论文部分内容阅读
氟硝丁酰胺(Flutamide)是一种非类固醇抗雄激素药物,曾报告对晚期前列腺癌姑息作用甚或优于乙烯雌酚。结构上,氟硝丁酰胺是一种酰基苯胺,它不抑制促性腺激素,无肾上腺皮质的活性。 25例前列腺癌转移到骨骼的患者分为两组:第一组12例,未用过激素治疗。第二组13例激素治疗失败。所有患者治疗前均进行过X线、骨放射同位素扫描、酸性和碱性磷酸酶、谷草转氨酶、乳酸脱氢酶、多项血液及尿分析,患者每隔6周就诊一次,每12周进行一次疗效评价。 第1组12例中有1例因仅接受治疗一周而不能评
Flutamide is a non-steroidal anti-androgen drug that has been reported to have a palliative effect on advanced prostate cancer and is even better than diethylstilbestrol. Structurally, flunitamide is an acylaniline that does not inhibit gonadotrophin and no adrenocortical activity. Twenty-five patients with prostate cancer metastasized to bone were divided into two groups: the first group consisted of 12 patients and had not received hormone therapy. The second group of 13 patients failed in hormone therapy. All patients received X-ray and bone radioisotope scans, acid and alkaline phosphatase, aspartate aminotransferase, lactate dehydrogenase, and multiple blood and urine analyses before treatment. Patients were treated every 6 weeks and every 12 weeks. Efficacy evaluation. 1 out of 12 patients in group 1 could not be evaluated because they only received treatment for one week